Extracellular Superoxide Dismutase Is Associated With Left Ventricular Geometry and Heart Failure in Patients With

Xiuwen Li1,2, Yingying Lin1,2, Shaohua Wang3

  • 1Guangdong Provincial Key Laboratory of Food, Nutrition and Health Guangzhou Guangdong Province China.

Insights

Serum Extracellular Superoxide Dismutase (Ec-SOD) activity decreases with abnormal left ventricular geometry and heart failure in cardiovascular disease patients. Lower Ec-SOD levels are linked to increased odds of developing heart failure, suggesting a protective role.

Area of Science:

  • Cardiology
  • Biochemistry
  • Pathophysiology

Background:

  • Extracellular superoxide dismutase (Ec-SOD) is a key antioxidant enzyme.
  • The association between Ec-SOD, left ventricular (LV) geometry, and heart failure (HF) in cardiovascular disease (CVD) patients remains unclear.

Purpose of the Study:

  • To investigate the relationship between serum Ec-SOD activity and LV geometry patterns.
  • To assess the association of serum Ec-SOD activity with the presence of HF in CVD patients.

Main Methods:

  • Cross-sectional study of 1047 CVD patients.
  • Standard echocardiography for LV geometry assessment.
  • Measurement of serum Ec-SOD activity.

Main Results:

  • Serum Ec-SOD activity showed a significant decreasing trend from normal geometry to abnormal LV geometry with HF.
  • Lower Ec-SOD levels were independently associated with increased odds of concentric and eccentric hypertrophy with and without HF.
  • Each 10 U/mL increase in Ec-SOD activity reduced the odds of HF by 16.5% to 40.4% depending on geometry.

Conclusions:

  • Serum Ec-SOD activity is independently associated with abnormal LV geometry and HF in CVD patients.
  • Ec-SOD may play a protective role in preventing LV structural remodeling and the development of HF.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
244
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
554
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.5K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
190
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
130
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
189